Follow
Zufar Mulyukov
Zufar Mulyukov
Verified email at novartis.com
Title
Cited by
Cited by
Year
Efficiency of database search for identification of mutated and modified proteins via mass spectrometry
PA Pevzner, Z Mulyukov, V Dancik, CL Tang
Genome research 11 (2), 290-299, 2001
1992001
Automatic pathway building in biological association networks
A Yuryev, Z Mulyukov, E Kotelnikova, S Maslov, S Egorov, A Nikitin, ...
BMC bioinformatics 7, 1-13, 2006
1212006
Ionization, dissociation, and level shifts of H 2+ in a strong dc or low-frequency ac field
Z Mulyukov, M Pont, R Shakeshaft
Physical Review A 54 (5), 4299, 1996
831996
Assessment of novel genome-wide significant gene loci and lesion growth in geographic atrophy secondary to age-related macular degeneration
F Grassmann, S Harsch, C Brandl, C Kiel, P Nürnberg, MR Toliat, ...
JAMA ophthalmology 137 (8), 867-876, 2019
332019
EULER-PCR: finishing experiments for repeat resolution
Z Mulyukov, PA Pevzner
Biocomputing 2002, 199-210, 2001
222001
Therapeutic response in the HAWK and HARRIER trials using deep learning in retinal fluid volume and compartment analysis
U Schmidt-Erfurth, Z Mulyukov, BS Gerendas, GS Reiter, D Lorand, ...
Eye 37 (6), 1160-1169, 2023
182023
Comparison of the efficacy of brolucizumab with natural disease progression in wet AMD using clinical data from the phase III HAWK and HARRIER trials and modelled placebo data
H Agostini, Z Mulyukov, M Tsilimbaris, P Calvo, F Bucher, D Gaucher, ...
Current eye research 45 (10), 1298-1301, 2020
182020
A plateau in high-order harmonic generation for a two-level atom
VP Krainov, ZS Mulyukov
Laser Phys 4, 544, 1994
181994
Characteristics and spatial distribution of structural features in age-related macular degeneration: a MACUSTAR Study report
M Saßmannshausen, C Behning, J Weinz, L Goerdt, JH Terheyden, ...
Ophthalmology Retina 7 (5), 420-430, 2023
112023
Neovascular age‐related macular degeneration: a visual acuity model of natural disease progression and ranibizumab treatment effect
Z Mulyukov, S Weber, E Pigeolet, A Clemens, T Lehr, A Racine
CPT: Pharmacometrics & Systems Pharmacology 7 (10), 660-669, 2018
112018
Breakup of H 2+ by one photon in the presence of a strong dc field
Z Mulyukov, R Shakeshaft
Physical Review A 63 (5), 053404, 2001
102001
Effect of retinal thickness variability on visual outcomes and fluid persistence in neovascular age-related macular degeneration: a post hoc analysis of the HAWK and HARRIER …
PU Dugel, CD Jhaveri, U Chakravarthy, CC Wykoff, RP Singh, R Hamilton, ...
Retina 42 (3), 511-518, 2022
92022
Acceleration of electrons under the ionization of atoms by focused laser pulse radiation
VP Krainov, ZS Mulyukov
Laser Physics 4 (3), 509-511, 1994
41994
A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis
U Schmidt-Erfurth, Z Mulyukov, BSS Gerendas, P Margaron, D Lorand, ...
Investigative Ophthalmology & Visual Science 61 (7), 1159-1159, 2020
32020
A Quasistationary State in a Zero-Range Potential Well Perturbed by a Superstrong Electric Field
VP Krainov, ZS Mulyukov
LASER PHYSICS 3 (3), 756-758, 1993
21993
Brolucizumab 12-and 16-Week Fixed Dosing Potential in Neovascular AMD: A post hoc Evaluation of Data from the HAWK and HARRIER Trials
M Singer, AM Khanani, A Wolf, R Flores, J Chhablani, A Clemens, K Gedif, ...
Ophthalmologica 245 (4), 315-322, 2022
12022
Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modelling approach
Y Xiong, E Pigeolet, Z Mulyukov, P Margaron, A Racine, A Clemens
Contemporary clinical trials 80, 34-39, 2019
12019
Part I. Break Up of the Hydrogen Molecular Ion by an Electric Field. Part II. Protein Identification via Mass Spectrometry
Z Mulyukov
University of Southern California, 2000
12000
Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report
D Rowen, J Carlton, JH Terheyden, RP Finger, N Wickramasekera, ...
Value in Health 27 (5), 642-654, 2024
2024
A computer-implemented system and method for assessing a level of activity of a disease or condition in a patient's eye
HS Chang, DFC Lorand, Z Mulyukov
US Patent App. 17/916,980, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20